At a glance
- Originator Trio Medicines
- Class Benzodiazepines; Gastric antisecretories; Pyridines; Small molecules
- Mechanism of Action Cholecystokinin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gastro-oesophageal reflux; Helicobacter infections; Neuroendocrine tumours
Most Recent Events
- 28 Feb 2021 No recent reports of development identified for phase-I development in Gastro-oesophageal-reflux in United Kingdom
- 28 Feb 2021 No recent reports of development identified for phase-I development in Helicobacter-infections in United Kingdom
- 28 Feb 2021 No recent reports of development identified for phase-I development in Neuroendocrine-tumours in United Kingdom